Document:

Exhibit 10.6.2

 

Galileo Acquisition Corp.

1049 Park Avenue, 14A

New York, NY 10028

 

[   ], 2019

 

Ladies and Gentlemen:

 

Galileo Acquisition Corp. (the “Company”),
a blank check company formed for the purpose of acquiring one or more businesses or entities (a “Business Combination”),
intends to register its securities under the Securities Act of 1933, as amended (“Securities Act”), in connection with
its initial public offering (the “IPO”), pursuant to a registration statement on Form S-1 (“Registration Statement”).

 

The undersigned, EarlyBirdCapital, Inc. (“EBC”),
as the representative of the underwriters in connection with the IPO, hereby commits that it will purchase 500,000, warrants of
the Company (“Warrants”), each Warrant entitling its holder to purchase one ordinary share of the Company, par value
$0.0001 per share (“Ordinary Share”) at $1.00 per Warrant, for a purchase price of $500,000 (the “Warrant Purchase
Price”).

 

The undersigned hereby agrees that it will
purchase its pro-rata share of an additional amount of warrants of the Company (“Over-Allotment Warrants”), up to a
maximum of 44,776 Over-Allotment Warrants, or a maximum purchase price of $44,776 (the “Over-Allotment Warrant Purchase Price,”
and together with the Warrant Purchase Price, the “Purchase Price”), in the event EBC exercises its over-allotment
option, such that the amount held in the trust account (as described in the Registration Statement) does not fall below $10.00
per share for each Ordinary Share sold in the IPO.

 

At least twenty-four (24) hours prior to the
effective date of the Registration Statement, the undersigned will cause the Warrant Purchase Price to be delivered to Continental
Stock Transfer and Trust Company (“CST”), escrow agent for the Company, by wire transfer as set forth in the instructions
to be provided to it by the Company hold in a non-interest bearing account until the Company consummates the IPO.

 

The consummation of the purchase and issuance
of the Warrants shall occur simultaneously with the consummation of the IPO and the consummation of the purchase and issuance of
the Over-Allotment Warrants shall occur simultaneously with the closing of any exercise of the over-allotment option related to
the IPO. Simultaneously with the consummation of the IPO, CST shall deposit the Warrant Purchase Price, without interest or deduction,
into the trust fund (“Trust Fund”) established by the Company for the benefit of the Company’s public shareholders
as described in the Registration Statement. If the Company does not complete the IPO within ten (10) days from the date of this
letter, the Purchase Price (without interest or deduction) will be returned to the undersigned.

 

Each of the Company and the undersigned acknowledges
and agrees that CST is serving hereunder solely as a convenience to the parties to facilitate the purchase of the Warrants and
Over-Allotment Warrants, if any, and CST’s sole obligation under this letter agreement is to act with respect to holding
and disbursing the Purchase Price for the Warrants and Over-Allotment Warrants, if any, as described above. CST shall not be liable
to the Company, EBC or the undersigned or any other person or entity in respect of any act or failure to act hereunder or otherwise
in connection with performing its services hereunder unless CST has acted in a manner constituting gross negligence or willful
misconduct. The Company shall indemnify CST against any claim made against it (including reasonable attorney’s fees) by reason
of it acting or failing to act in connection with this letter agreement except as a result of its gross negligence or willful misconduct.
CST may rely and shall be protected in acting or refraining from acting upon any written notice, instruction or request furnished
to it hereunder and believed by it to be genuine and to have been signed or presented by the proper party or parties.

 

    

     

    

 

The Warrants and Over-Allotment Warrants will
be identical to the warrants to be sold by the Company in the IPO. Additionally, the undersigned agrees:

  

		·	the
undersigned will not participate in any liquidation distribution with respect to the Warrants, Over-Allotment Warrants and underlying
Ordinary Shares (but will participate in liquidation distributions with respect to any units or Ordinary Shares purchased by the
undersigned in the IPO or in the open market) if the Company fails to consummate a Business Combination;

 

	 	·	that the Warrants, Over-Allotment Warrants and underlying Ordinary Shares will not be transferable until after the consummation of a Business Combination except (i) to the Company’s officers, directors or their respective affiliates; (ii) transfers to the undersigned’s affiliates or its members upon its liquidation, (iii) to relatives and trusts for estate planning purposes, (iv) by virtue of the laws of descent and distribution upon death, (v) pursuant to a qualified domestic relations order, (vi) by private sales made in connection with the consummation of a Business Combination at prices no greater than the price at which the Warrants or Over-Allotment Warrants were originally purchased or (vii) to the Company for cancellation in connection with the consummation of a Business Combination, in each case (except for clause vii) where the transferee agrees to the terms of the transfer restrictions;

 

	 	·	the Warrants and Over-Allotment Warrants will be subject to customary registration rights, pursuant to a Registration Rights Agreement on terms agreed upon by the Company and the underwriters in the IPO to be filed as an exhibit to the Registration Statement; and

 

	 	·	the Warrants and Over-Allotment Warrants will include any additional terms or restrictions as is customary in other similarly structured blank check company offerings or as may be reasonably required by the underwriters in the IPO in order to consummate the IPO, each of which will be set forth in the Registration Statement.

 

The Warrants and Over-Allotment Warrants (and
underlying securities) are deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)
of the FINRA Manual, commencing on the effective date of the Registration Statement. Pursuant to FINRA Rule 5110(g), these securities
will not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging,
short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for
a period of 180 days immediately following the effective date of the Registration Statement or commencement of sales of the public
offering, except to any underwriter and selected dealer participating in the offering and their bona fide officers or partners,
provided that all securities so transferred remain subject to the lockup restriction above for the remainder of the time period.

 

The undersigned acknowledges and agrees that
the purchaser of the Warrants and Over-Allotment Warrants will execute agreements in form and substance typical for transactions
of this nature necessary to effectuate the foregoing agreements and obligations prior to the consummation of the IPO as are reasonably
acceptable to the undersigned, including but not limited to an insider letter.

 

The undersigned hereby represents and warrants
that:

 

		(a)	it
has been advised that the Warrants and Over-Allotment Warrants have not been registered under the Securities Act;

 

	 	(b)	it will be acquiring the Warrants and Over-Allotment Warrants for its account for investment purposes only;

 

    

     

    

 

	 	(c)	it has no present intention of selling or otherwise disposing of the Warrants and Over-Allotment Warrants in violation of the securities laws of the United States;

 

	 	(d)	it is an “accredited investor” as defined by Rule 501 of Regulation D promulgated under the Securities Act of 1933, as amended;

 

	 	(e)	it has had both the opportunity to ask questions and receive answers from the officers and directors of the Company and all persons acting on its behalf concerning the terms and conditions of the offer made hereunder;

 

	 	(f)	it is familiar with the proposed business, management, financial condition and affairs of the Company;

 

	 	(g)	it has full power, authority and legal capacity to execute and deliver this letter and any documents contemplated herein or needed to consummate the transactions contemplated in this letter; and

 

	 	(h)	this letter constitutes its legal, valid and binding obligation, and is enforceable against it.

 

[remainder of page intentionally left
blank]

  

This letter agreement constitutes the entire
agreement between the undersigned and the Company with respect to the purchase of the Warrants and Over-Allotment Warrants, and
supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written and oral, with
respect to the same.

 

	 	Very truly yours,
	 	 
	 	EARLYBIRDCAPITAL, INC.
	 	 
	 	By:	                      
	 	Name:
	 	Title:

 

	Accepted and Agreed:	 
	 	 
	GALILEO ACQUISITION CORP.	 
	 	 	 
	By:  		 
	 	Name: Luca Giacometti	 
	 	Title:   Chief Executive OfficerExhibit 4.2

 

FIRST AMENDMENT TO RIGHTS AGREEMENT

THIS FIRST AMENDMENT
TO RIGHTS AGREEMENT (this “First Amendment”) is entered into as of October 6, 2019, and shall be
effective as of the Effective Date (defined below), by and among Surge Components, Inc., a Delaware corporation (the “Company”),
and Continental Stock Transfer & Trust Company as Rights Agent (the “Rights Agent” and, together
with the Company, the “Parties”). Capitalized terms used but not otherwise defined herein shall have
the respective meanings assigned to such terms in the Rights Agreement dated as of October 7, 2016 between the Company and the
Rights Agent.

RECITALS

WHEREAS,
the Company and the Rights Agent are parties to that certain Rights Agreement, dated as of October 7, 2016 (the “Rights
Agreement”), pursuant to which the Company granted certain rights to shareholders of the Company’s common stock;
and

WHEREAS,
pursuant to Section 7(a) of the Rights Agreement, the Board has determined that it is in the best interests of the Company to extend
the Expiration Date of the Rights; and

WHEREAS, the
Parties hereby agree to the following amendments to the Rights Agreement.

NOW, THEREFORE

		1.	Amendment to Section 7(a) of the Rights Agreement. Section 7(a) of the Rights Agreement
is hereby amended by deleting it in its entirety and replacing it with the following:

“(a)
Subject to Section 7(e) hereof, the registered holder of any Rights Certificate may exercise the Rights evidenced thereby (except
as otherwise provided herein including, without limitation, in the restrictions on exercisability set forth in Sections 9(c),
11(a)(iii) and 23(a) hereof) in whole or in part at any time after the Distribution Date upon surrender of the Rights Certificate,
with the form of election to purchase and the certificate on the reverse side thereof properly completed and duly executed, to
the Rights Agent at the office of the Rights Agent designated for such purpose, together with payment of the Exercise Price for
each one one-thousandth of a share of Preferred Stock (or Common Stock, other securities, cash or other assets, as the case may
be) as to which the Rights are exercised prior to the earliest of (i) the Close of Business on October 7, 2022 or such later date
as may be established by the Board prior to the expiration of the Rights as long as the extension is submitted to the stockholders
of the Company for ratification at the next annual meeting of stockholders succeeding such extension (the “Final Expiration
Date”); (ii) the time at which the Rights are redeemed pursuant to Section 23 hereof (the “Redemption Date”);
(iii) the time at which the Rights are exchanged pursuant to Section 24 hereof (the “Exchange Date”); (iv)
the closing of any merger or other acquisition transaction involving the Company pursuant to an agreement of the type described
in Section 13(f) at which time the Rights are terminated; (v) the Close of Business on the first day after the Company’s
2019 annual meeting of stockholders, if Stockholder Approval has not been obtained at the Company’s 2019 annual meeting
of stockholders (the “Early Expiration Date”); (vi) the Close of Business on the effective date of the repeal
of Section 382 of the Code if the Board determines that this Agreement is no longer necessary or desirable for the preservation
of Tax Benefits; and (vii) the Close of Business on the first day of a taxable year of the Company to which the Board determines
that no Tax Benefits are available to be carried forward (the earliest of (i) – (vii) being herein referred to as the “Expiration
Date”).

     

     

    

 

		2.	Amendment to Exhibit B of the Rights Agreement. Exhibit B Summary of Rights to Purchase
Series D Preferred Stock of the Rights Agreement (“Exhibit B”) is hereby amended as follows:

		a.	Amendment to the First Paragraph of Exhibit B. The first paragraph of Exhibit B is hereby
amended by deleting it in its entirety and replacing it with the following:

“The Board
of Directors (the “Board”) of Surge Components, Inc., a Delaware corporation (the “Company”),
declared a dividend of one preferred share purchase right (a “Right”) for each outstanding share of common stock,
par value $0.001 per share, of the Company (the “Common Stock”). The dividend was payable on October 7, 2016
(the “Record Date”) to the stockholders of record on that date. Each Right entitles the registered holder to
purchase from the Company one one-thousandth of a share of Series D Preferred Stock, par value $0.001 per share, of the Company
(the “Preferred Stock”) at a price of $5.00 per one one-thousandth of a share of Preferred Stock (the “Purchase
Price”), subject to adjustment. The description and terms of the Rights are set forth in a Rights Agreement dated as
of October 7, 2016, as the same may be amended from time to time (the “Rights Agreement”), between the Company
and Continental Stock Transfer & Trust Company, as Rights Agent (the “Rights Agent”).”

 

		3.	Effective Date. This First Amendment shall become effective immediately (the “Effective
Date”).

		4.	Miscellaneous. Except as expressly provided in this First Amendment, all of the terms and
provisions in the Rights Agreement are and shall remain in full force and effect, on the terms and subject to the conditions set
forth therein. This First Amendment does not constitute, directly or by implication, an amendment or waiver of any provision of
the Rights Agreement, or any other right, remedy, power or privilege of any party thereto, except as expressly set forth herein.
Any reference to the Rights Agreement in the Rights Agreement or any other agreement, document, instrument or certificate entered
into or issued in connection therewith shall hereinafter mean the Rights Agreement, as amended by this First Amendment on the Effective
Date (or as the Rights Agreement may be further amended or modified after the Effective Date in accordance with the terms thereof).
The terms of this First Amendment shall be governed by, enforced and construed and interpreted in a manner consistent with the
provisions of the Rights Agreement.

[REMAINDER OF PAGE INTENTIONALLY
LEFT BLANK; SIGNATURE PAGE FOLLOWS]

     

     

    

 

IN WITNESS WHEREOF,
each party hereto has signed or has caused to be signed by its officer thereunto duly authorized this First Amendment to Rights
Agreement as of the date first above written.

	 	COMPANY:
	 	SURGE COMPONENTS, INC. 
	 	 	 
	 	By:	 
	 	 	Name:  
	 	 	Title:  
	 	 	 
	 	RIGHTS AGENT:
	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY
	 	 	 
	 	By:	 
	 	 	Name:  
	 	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}]]